Carrot, the virtual reality eye care company formerly known as Virtual Field, has finalized an agreement to acquire GreenMan Vision, the developer behind the InSightVR platform. This tool specializes in educating cataract patients about intraocular lens (IOL) options before surgery. The acquisition will merge InSightVR‘s IOL simulation capabilities into Carrot’s existing VR platform, enabling patients to preview how different artificial lenses would affect their vision in real-world scenarios.
The InSightVR system uses detailed eye measurements to simulate everyday tasks, such as reading text or driving at night. Patients can assess trade-offs like reduced dependency on glasses, glare, or light halos. The platform was developed by cataract surgeons Dr. Michael Greenwood and Dr. Brandon Baartman of Vance Thompson Vision, who emphasized its design principle: delivering accurate outcomes without exaggerated claims.
Carrot’s current VR platform already provides visual field testing and other vision assessments through a headset, incorporating AI analysis, automated workflows, and electronic health record integration. The addition of InSightVR will broaden Carrot’s accessibility for surgeons and patients, according to Matt Larson, CEO of GreenMan Vision. This expansion aligns with Carrot’s goal of enhancing pre-surgical decision-making through immersive technology.
Read Also: States seek unified AI rules to avoid delays in patient
While Carrot focuses on cataract simulations, other companies have explored VR for vision-related applications. In 2022, Visibly secured FDA clearance for an at-home visual acuity test using a touchscreen and computer. The previous year, Ophthalmic Sciences launched IOPerfect, a VR system for monitoring glaucoma through intraocular pressure tracking. Earlier in 2021, SyncThink received approval for EYE-SYNC, a VR and eye-tracking tool for diagnosing sports-related concussions.
For patients, the integration of InSightVR into Carrot’s platform introduces a more precise approach to pre-surgery planning. Instead of relying on vague descriptions or post-operative guesswork, patients can now experience how different lens choices impact their daily activities—whether reading fine print or moving through poorly lit areas. The technology translates clinical data into practical, relatable scenarios, empowering patients to select vision correction options with greater confidence.
